Literature DB >> 27218663

Roles of FGFR in oral carcinogenesis.

Xiaoyan Xie1, Zhiyong Wang1, Fangman Chen1, Yao Yuan1, Jiayi Wang1, Rui Liu1, Qianming Chen1.   

Abstract

Fibroblast growth factor receptors (FGFRs) play essential roles in organ development during the embryonic period, and regulate tissue repair in adults. Accumulating evidence suggests that alterations in FGFR signalling are involved in diverse types of cancer. In this review, we focus on aberrant regulation of FGFRs in pathogenesis of oral squamous cell carcinoma (OSCC), including altered expression and subcellular location, aberrant isoform splicing and mutations. We also provide an overview of oncogenic roles of each FGFR and its downstream signalling pathways in regulating OSCC cell proliferation and metastasis. Finally, we discuss potential application of FGFRs as anti-cancer targets in the preclinical environment and in clinical practice.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27218663      PMCID: PMC6495773          DOI: 10.1111/cpr.12260

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  86 in total

1.  Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.

Authors:  Xiuqin Zhang; Omar A Ibrahimi; Shaun K Olsen; Hisashi Umemori; Moosa Mohammadi; David M Ornitz
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

2.  Somatic mutations of the protein kinase gene family in human lung cancer.

Authors:  Helen Davies; Chris Hunter; Raffaella Smith; Philip Stephens; Chris Greenman; Graham Bignell; Jon Teague; Adam Butler; Sarah Edkins; Claire Stevens; Adrian Parker; Sarah O'Meara; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Jody Clements; Jennifer Cole; Ed Dicks; Ken Edwards; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; Rebecca Shepherd; Alexandra Small; Helen Solomon; Yvonne Stephens; Calli Tofts; Jennifer Varian; Anthony Webb; Sofie West; Sara Widaa; Andrew Yates; Francis Brasseur; Colin S Cooper; Adrienne M Flanagan; Anthony Green; Maggie Knowles; Suet Y Leung; Leendert H J Looijenga; Bruce Malkowicz; Marco A Pierotti; Bin T Teh; Siu T Yuen; Sunil R Lakhani; Douglas F Easton; Barbara L Weber; Peter Goldstraw; Andrew G Nicholson; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

3.  The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.

Authors:  Brittany C Parker; Matti J Annala; David E Cogdell; Kirsi J Granberg; Yan Sun; Ping Ji; Xia Li; Joy Gumin; Hong Zheng; Limei Hu; Olli Yli-Harja; Hannu Haapasalo; Tapio Visakorpi; Xiuping Liu; Chang-Gong Liu; Raymond Sawaya; Gregory N Fuller; Kexin Chen; Frederick F Lang; Matti Nykter; Wei Zhang
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

Review 4.  Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.

Authors:  Steven B Chinn; Jeffrey N Myers
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

5.  PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.

Authors:  Jing Chen; Daniel J Deangelo; Jeffery L Kutok; Ifor R Williams; Benjamin H Lee; Martha Wadleigh; Nicole Duclos; Sarah Cohen; Jennifer Adelsperger; Rachel Okabe; Allison Coburn; Ilene Galinsky; Brian Huntly; Pamela S Cohen; Thomas Meyer; Doriano Fabbro; Johannes Roesel; Lolita Banerji; James D Griffin; Sheng Xiao; Jonathan A Fletcher; Richard M Stone; D Gary Gilliland
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-24       Impact factor: 11.205

6.  Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma.

Authors:  Sylvia Streit; Johannes Bange; Alexander Fichtner; Stephan Ihrler; Wolfgang Issing; Axel Ullrich
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

7.  Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.

Authors:  Tsutomu Sato; Takashi Oshima; Kazue Yoshihara; Naoto Yamamoto; Roppei Yamada; Yasuhiko Nagano; Shoichi Fujii; Chikara Kunisaki; Manabu Shiozawa; Makoto Akaike; Yasushi Rino; Katsuaki Tanaka; Munetaka Masuda; Toshio Imada
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

8.  Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.

Authors:  Sergei Roumiantsev; Daniela S Krause; Carola A Neumann; Christopher A Dimitri; Frances Asiedu; Nicholas C P Cross; Richard A Van Etten
Journal:  Cancer Cell       Date:  2004-03       Impact factor: 31.743

9.  Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer.

Authors:  Anna Ansell; Lovisa Farnebo; Reidar Grénman; Karin Roberg; Lena K Thunell
Journal:  Oral Oncol       Date:  2008-05-19       Impact factor: 5.337

10.  A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.

Authors:  A Yayon; Y Zimmer; G H Shen; A Avivi; Y Yarden; D Givol
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  4 in total

1.  1, 6-O, O-Diacetylbritannilactone from Inula britannica Induces Anti-Tumor Effect on Oral Squamous Cell Carcinoma via miR-1247-3p/LXRα/ABCA1 Signaling.

Authors:  Shaohua Zheng; Lihua Li; Na Li; Yi Du; Nan Zhang
Journal:  Onco Targets Ther       Date:  2020-10-29       Impact factor: 4.147

Review 2.  Genetic alterations and clinical dimensions of oral cancer: a review.

Authors:  Keerthana Karunakaran; Rajiniraja Muniyan
Journal:  Mol Biol Rep       Date:  2020-10-21       Impact factor: 2.316

3.  Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.

Authors:  Yue Jing; Yan Yang; Fengyao Hao; Yuxian Song; Xiaoxin Zhang; Ye Zhang; Xiaofeng Huang; Qingang Hu; Yanhong Ni
Journal:  Biosci Rep       Date:  2018-11-20       Impact factor: 3.840

4.  Psorachromene Suppresses Oral Squamous Cell Carcinoma Progression by Inhibiting Long Non-coding RNA GAS5 Mediated Epithelial-Mesenchymal Transition.

Authors:  Tong-Hong Wang; Yann-Lii Leu; Chin-Chuan Chen; Tzong-Ming Shieh; Jang-Hau Lian; Chi-Yuan Chen
Journal:  Front Oncol       Date:  2019-11-05       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.